Rezolute (RZLT) Other Non-Current Assets (2012 - 2026)
Rezolute (RZLT) posted Other Non-Current Assets of $2.4 million for Q1 2026, up 1.71% sequentially from $2.4 million in Q4 2025, and down 16.48% YoY from $2.9 million in Q1 2025.
Analysis
Rezolute (RZLT) Other Non-Current Assets (2012 - 2026) Analysis & Trends
Rezolute has reported Other Non-Current Assets for 14 years, with the latest figure at $2.4 million in Q1 2026.
- Quarterly Other Non-Current Assets fell 16.48% year-over-year to $2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.4 million (down 16.48% YoY) and the FY2025 annual result came in at $2.9 million, up 59.14% from the prior year.
- Other Non-Current Assets grew to $2.4 million in Q1 2026 per RZLT's latest filing, from $2.4 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $5.0 million in Q1 2022 and troughed at $148000.0 in Q2 2022.
- A 5-year average of $1.7 million and a median of $1.8 million in 2024 frame the typical range for Other Non-Current Assets.
- The widest YoY moves for Other Non-Current Assets: up 41566.67% in 2022, down 97.04% in 2022.
- Over 5 years, Other Non-Current Assets stood at $148000.0 in 2022, then soared by 213.51% to $464000.0 in 2023, then surged by 510.34% to $2.8 million in 2024, then retreated by 15.18% to $2.4 million in 2025, then rose by 1.71% to $2.4 million in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $2.4 million, $2.4 million, and $2.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 618.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 42.45 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 109.58 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 65.13 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 62.96 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Rezolute | 477.02 Mn | 477.02 Mn | - | 2.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 2.44 Mn |
| Dec 31, 2025 | 2.40 Mn |
| Sep 30, 2025 | 2.68 Mn |
| Jun 30, 2025 | 2.93 Mn |
| Mar 31, 2025 | 2.93 Mn |
| Dec 31, 2024 | 2.83 Mn |
| Sep 30, 2024 | 1.84 Mn |
| Jun 30, 2024 | 1.84 Mn |
| Mar 31, 2024 | 1.84 Mn |
| Dec 31, 2023 | 464,000.00 |
| Sep 30, 2023 | 148,000.00 |
| Jun 30, 2023 | 148,000.00 |
| Mar 31, 2023 | 148,000.00 |
| Dec 31, 2022 | 148,000.00 |
| Sep 30, 2022 | 148,000.00 |
| Jun 30, 2022 | 148,000.00 |
| Mar 31, 2022 | 5.00 Mn |
| Dec 31, 2021 | 5.00 Mn |
| Sep 30, 2021 | 72,000.00 |
| Jun 30, 2021 | 191,000.00 |